Roxane ordered to pay $2.3m attorneys' fees

23-05-2017

Roxane ordered to pay $2.3m attorneys' fees

zerbor / iStockphoto.com

A district court has ordered Roxane Laboratories to pay Camber Pharmaceuticals and InvaGen Pharmaceuticals $2.3 million in attorneys’ fees. 


Roxane Laboratories, patent, Camber Pharmaceuticals, InvaGen Pharmaceuticals, ANDA, FDA

LSIPR